Abstract

SANCHEZ-MONROY, Jorge  and  MUNUERA RUFAS, Inés. Influence of Intravitreal Treatment on Intraocular Pressure in Patients with Glaucoma and Macular Degeneration. Rev Cubana Oftalmol [online]. 2022, vol.35, n.3  Epub Sep 01, 2022. ISSN 1561-3070.

In recent years, the emergence of antiangiogenic drugs has revolutionized the treatment of numerous retinal diseases, their association with ocular hypertension after injections has been the subject of study on numerous occasions. We present a clinical case of a patient with glaucoma and age-related macular degeneration in which the relationship between the administration of intravitreal antiangiogenic drugs and the elevation of intraocular pressure, in the short and long term, was studied. The prescribing of antiangiogenic drugs is currently the most widely used ophthalmologic procedure in practices worldwide. Intravitreal administration has been associated with the production of a transitory hypertensive peak in the acute setting and long-term elevation of intraocular pressure. A narrow interval between injections (< 8 weeks), a high number of punctures (> 7 per year), patients with narrow chamber, phakic and with a previous diagnosis of glaucoma are the main risk factors for the development of sustained intraocular pressure elevation after intravitreal treatment with antiangiogenics. Identifying patients at high risk of developing ocular hypertension after intravitreal injections and adopting measures to reduce this risk, such as the administration of topical hypotensives before the injection, is essential to improve their eyesight health. The case of a 78-year-old female patient with a diagnosis of primary open-angle glaucoma of five years of evolution in both eyes is presented.

Keywords : antiangiogenics; macular degeneration; glaucoma; ocular hypertension.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )